Reviewed,
UniProtKB/Swiss-Prot Q99J72 (ABEC3_MOUSE)
Last modified
June 10, 2008.
Version 54.
History...
Clusters with 100%,
90%,
50% identity |
Documents (3) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | DNA dC->dU-editing enzyme APOBEC-3 Also known as: EC 3.5.4.- Apolipoprotein B mRNA-editing complex 3 Arp3 CEM15 CEM-15 | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus | ||
| Protein existence | Evidence at transcript level. |
General annotation (Comments)
| Function | Probable human APOBEC3G ortholog. Has DNA deaminase (cytidine deaminase) activity. Mediates G-to-A hypermutation in newly synthesized HIV-1 viral DNA and is thus able to prevent HIV-1 infectivity in vitro, in the presence and absence of HIV-1 VIF (virion infectivity factor). |
| Cofactor | Zinc By similarity. |
| Subcellular location | Cytoplasm By similarity. Nucleus By similarity. Note=Mainly cytoplasmic, small amount are found in the nucleus By similarity. |
| Tissue specificity | Expressed in spleen, node and lung. |
| Polymorphism | Polymorphism seems to be an important factor for the ability of the protein to prevent HIV-1 infectivity in vitro. The protein derived from MDTF and EL4 cell lines are unable to reduce HIV-1 infectivity, while the protein derived from L1.2, 3T3 and splenocytes are able to do it, in the presence and absence of HIV-1 VIF (virion infectivity factor). |
| Miscellaneous | HIV-1 VIF (virion infectivity factor) does not bind to mouse APOBEC3. |
| Sequence similarities | Belongs to the cytidine and deoxycytidylate deaminase family. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Ligand | Metal-binding Zinc |
| Molecular function | Hydrolase |
Gene Ontology (GO) | |
| None. [Check GOA] | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] Isoform 1 (identifier: Q99J72-1) Isoform 2 (identifier: Q99J72-2) Isoform 3 (identifier: Q99J72-3) Isoform 4 (identifier: Q99J72-4) |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||
Molecule processing | ||||||||
|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 429 | 429 | DNA dC->dU-editing enzyme APOBEC-3 | |||||
Sites | ||||||||
| Active site | 73 | 1 | Proton donor By similarity | |||||
| Metal binding | 71 | 1 | Zinc By similarity | |||||
| Metal binding | 105 | 1 | Zinc By similarity | |||||
| Metal binding | 108 | 1 | Zinc By similarity | |||||
| Metal binding | 288 | 1 | Zinc By similarity | |||||
| Metal binding | 316 | 1 | Zinc By similarity | |||||
| Metal binding | 319 | 1 | Zinc By similarity | |||||
Natural variations | ||||||||
| Alternative sequence | 198 – 230 | 33 | Missing in isoform 3 and isoform 4. | |||||
| Alternative sequence | 409 – 429 | 21 | SWGLQ…GPPMS → VRTTLLQGPAS in isoform 2. | |||||
| Alternative sequence | 409 – 429 | 21 | SWGLQ…GPPMS → SRSHAS in isoform 3. | |||||
| Natural variant | 20 | 1 | L → V in cell line MDTF. | |||||
| Natural variant | 31 | 1 | K → E in cell line MDTF. | |||||
| Natural variant | 34 – 35 | 2 | GY → PF in cell line MDTF. | |||||
| Natural variant | 34 | 1 | G → R in cell lines L1.2 and 3T3. | |||||
| Natural variant | 37 – 38 | 2 | KG → ID in cell lines L1.2 and 3T3. | |||||
| Natural variant | 38 | 1 | G → K in cell line MDTF. | |||||
| Natural variant | 111 | 1 | Q → R in cell line L1.2. | |||||
| Natural variant | 112 – 113 | 2 | IV → VL in cell lines L1.2 and 3T3. | |||||
| Natural variant | 112 | 1 | I → V in cell line MDTF. | |||||
| Natural variant | 128 | 1 | S → F in cell line MDTF. | |||||
| Natural variant | 134 – 139 | 6 | VQDPET → IRNPEN in cell line MDTF. | |||||
| Natural variant | 134 – 135 | 2 | VQ → IR in cell lines L1.2 and 3T3. | |||||
| Natural variant | 139 – 140 | 2 | TQ → NQL in cell line 3T3. | |||||
| Natural variant | 139 | 1 | T → N in cell line L1.2. | |||||
| Natural variant | 148 | 1 | Q → L in cell line MDTF. | |||||
| Natural variant | 162 – 163 | 2 | KK → EE in cell line MDTF. | |||||
| Natural variant | 181 | 1 | R → K in cell lines L1.2 and 3T3. | |||||
| Natural variant | 198 – 230 | 33 | Missing in cell line MDTF. | |||||
| Natural variant | 230 – 235 | 6 | GRRMDP → RRRVHL in cell line 3T3. | |||||
| Natural variant | 233 – 235 | 3 | MDP → VHL | |||||
| Natural variant | 234 – 235 | 2 | DP → SL in cell line MDTF. | |||||
| Natural variant | 248 | 1 | Q → L in cell line MDTF. | |||||
| Natural variant | 258 – 259 | 2 | RM → GV in cell line 3T3. | |||||
| Natural variant | 258 | 1 | R → G in cell line L1.2. | |||||
| Natural variant | 264 | 1 | C → F in cell line MDTF. | |||||
| Natural variant | 269 | 1 | Q → W in cell line MDTF. | |||||
| Natural variant | 274 | 1 | A → E in cell line MDTF. | |||||
| Natural variant | 284 – 296 | 13 | Missing in cell line MDTF. | |||||
| Natural variant | 306 | 1 | T → I in cell lines L1.2 and 3T3. | |||||
| Natural variant | 314 | 1 | S → G in cell line EL4. | |||||
| Natural variant | 328 | 1 | R → K in cell line MDTF. | |||||
| Natural variant | 381 | 1 | N → S in cell line MDTF. | |||||
| Natural variant | 387 | 1 | W → R in splenocytes. | |||||
| Natural variant | 394 – 395 | 2 | II → KT in cell line MDTF. | |||||
| Natural variant | 399 | 1 | T → A in cell line L1.2. | |||||
| Natural variant | 404 | 1 | R → C in cell lines MDTF and 3T3. | |||||
| Natural variant | 404 | 1 | R → H in cell line L1.2. | |||||
Experimental info | ||||||||
| Sequence conflict | 203 | 1 | P → S Ref.3 | |||||
| Sequence conflict | 227 | 1 | C → W Ref.3 | |||||
| Sequence conflict | 230 | 1 | G → R Ref.2 | |||||
| Sequence conflict | 410 – 414 | 5 | WGLQD → RSHAS in BAC34023. Ref.1 | |||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed: 16141072] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), VARIANTS ARG-34; 37-ILE-ASP-38; 112-VAL-LEU-113; 134-ILE-ARG-135; ASN-139; LYS-181; 233-VAL-HIS-LEU-235; GLY-258; ILE-306 AND HIS-404. Strain: C57BL/6J. Tissue: Hippocampus and Retina. |
| [2] | Mariani R., Landau N.R. Submitted (FEB-2004) to UniProtKB Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 4), VARIANTS. Strain: C57BL/6J. Tissue: Spleen. |
| [3] | "Initial sequencing and comparative analysis of the mouse genome." Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., Agarwala R., Ainscough R., Alexandersson M., An P., Antonarakis S.E., Attwood J., Baertsch R., Bailey J., Barlow K., Beck S., Berry E., Birren B. |

Clusters with